670 filings
Page 5 of 34
424B3
t1bfiymgz 540gb
12 Mar 21
Prospectus supplement
4:14pm
EFFECT
g0m0071ec04q
10 Mar 21
Notice of effectiveness
12:15am
CORRESP
zxojdbbm
5 Mar 21
Correspondence with SEC
12:00am
UPLOAD
lul3y3g6fnxi8fc35
4 Mar 21
Letter from SEC
12:00am
424B5
7m60y
23 Feb 21
Prospectus supplement for primary offering
4:27pm
8-K
jdg4v
23 Feb 21
Other Events
4:05pm
8-K
nr525t2spb
22 Feb 21
Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
4:26pm
8-K
tsk47
12 Jan 21
Entry into a Material Definitive Agreement
6:05am
424B3
r2libvgo xgdu
6 Nov 20
Prospectus supplement
4:46pm
EFFECT
dxjdybpfv85lxq1
6 Nov 20
Notice of effectiveness
12:15am
CORRESP
sp7hd
3 Nov 20
Correspondence with SEC
12:00am
UPLOAD
iggzco2o dhiz
3 Nov 20
Letter from SEC
12:00am
424B5
b6c33sony5c99
23 Oct 20
Prospectus supplement for primary offering
5:09pm
8-K
zuzqzzxo ta2
23 Oct 20
Entry into a Material Definitive Agreement
4:14pm
8-K
uys5kb5
22 Oct 20
Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
4:16pm